本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Prelude Therapeutics Inc

0.7987
-0.0113-1.40%
成交量:7.68萬
成交額:6.21萬
市值:4,405.20萬
市盈率:-0.48
高:0.8499
開:0.7939
低:0.7800
收:0.8100
資料載入中...
2024/05/04

SEC問詢函

Form CORRESP - Correspondence
2024/05/02

SEC問詢函

Form CORRESP - Correspondence
2024/04/10

重要事件披露

Form 8-K - Current report
2024/02/16

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/15

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/14

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/11

重要事件披露

Form 8-K - Current report
2023/11/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

重要事件披露

Form 8-K - Current report
2023/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/06/22

重要事件披露

Form 8-K - Current report
2023/06/02

重要事件披露

Form 8-K - Current report
2023/05/24

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/24

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/20

重要事件披露

Form 8-K - Current report